BDBM508761 Method #6::US11071721, Example 37::US11071721, Example 6::US11607396, Example 6

SMILES Fc1ccccc1C1OCCn2nc(nc12)C(=O)N1CC(F)(F)C1

InChI Key InChIKey=RHTGYLULMBEDCF-UHFFFAOYSA-N

Data  3 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 508761   

LigandPNGBDBM508761(US11071721, Example 37 | Method #6 | US11071721, E...)
Affinity DataKi:  722nMAssay Description:The ability of the receptor interacting protein kinase (RIPK1) to catalyze the hydrolysis of adenosine-5′-triphosphate (ATP) is monitored using...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2023
Entry Details
US Patent

LigandPNGBDBM508761(US11071721, Example 37 | Method #6 | US11071721, E...)
Affinity DataKi:  722nMAssay Description:The ability of the receptor interacting protein kinase (RIPK1) to catalyze the hydrolysis of adenosine-5′-triphosphate (ATP) is monitored using...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

LigandPNGBDBM508761(US11071721, Example 37 | Method #6 | US11071721, E...)
Affinity DataKi:  1.40E+3nMAssay Description:The ability of the receptor interacting protein kinase (RIPK1) to catalyze the hydrolysis of adenosine-5′-triphosphate (ATP) is monitored using...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent